Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medinol v. Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Stent maker Medinol's ongoing suit against distributor Boston Scientific Chairman Pete Nicholas and CFO Larry Best will be allowed to proceed alongside other suits between the parties related to alleged supply agreement violations under a New York federal court ruling denying the execs' motion for dismissal. The court's action, which also dismissed personal claims against other Boston Scientific employees, comes three months after dismissal of similar claims against the individual managers of Medinol. Boston Scientific maintains the actions are preliminary and not expected to adversely impact the overall litigation. The New York proceedings are separate from ongoing shareholder rights litigation brought against Medinol in Israel by minority stakeholder Boston Scientific...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT015904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel